Treatment of symptomatic congenital cytomegalovirus infection with valganciclovir
CFM Jansen, MC Toet, CMA Rademaker… - Journal of perinatal …, 2005 - degruyter.com
… Valganciclovir (VGCV) is a prodrug of GCV with improved … treatment to oral GCV w7x for
treatment of neonates. We present a neonate with congenital CMV infection, who was treated …
treatment of neonates. We present a neonate with congenital CMV infection, who was treated …
Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients
RS Cvetkovic, K Wellington - Drugs, 2005 - Springer
… , valganciclovir appears to have some advantages over ganciclovir. Therefore, when used as
prophylaxis against CMV infection … of CMV retinitis in patients with AIDS, oral valganciclovir …
prophylaxis against CMV infection … of CMV retinitis in patients with AIDS, oral valganciclovir …
Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts
P Reusser - Expert opinion on investigational drugs, 2001 - Taylor & Francis
… review, the presently established treatment approaches for CMV infection and disease in …
for valganciclovir use; in the second part of the article, data on valganciclovir generated from …
for valganciclovir use; in the second part of the article, data on valganciclovir generated from …
Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir
J Fellay, JP Venetz, JD Aubert, C Seydoux… - Transplantation …, 2005 - Elsevier
… ) in high-risk transplant recipients and for the treatment of CMV retinitis in AIDS patients.
We used VGC for the treatment of CMV infection (viremia without symptoms) or disease (CMV …
We used VGC for the treatment of CMV infection (viremia without symptoms) or disease (CMV …
Valganciclovir: oral prevention and treatment of cytomegalovirus in the immunocompromised host
RB Freeman - Expert Opinion on Pharmacotherapy, 2004 - Taylor & Francis
… as prophylaxis in bone marrow or lung transplant recipients, or using valganciclovir as
treatment for active CMV infection in solid organ transplant recipients. In addition, although there …
treatment for active CMV infection in solid organ transplant recipients. In addition, although there …
Use of valganciclovir for prevention and treatment of cytomegalovirus disease
DR Snydman - Clinical Infectious Diseases, 2008 - academic.oup.com
… management of cytomegalovirus infection in the immunocompromised host. Valganciclovir
… The administration of 900 mg of valganciclovir orally is comparable to a dose of intravenous …
… The administration of 900 mg of valganciclovir orally is comparable to a dose of intravenous …
[HTML][HTML] Valganciclovir for symptomatic congenital cytomegalovirus disease
DW Kimberlin, PM Jester, PJ Sánchez… - … England Journal of …, 2015 - Mass Medical Soc
… -controlled trial of valganciclovir therapy in neonates with symptomatic congenital CMV
disease, … Although congenital CMV infection is rare overall, it accounts for 21% of children with …
disease, … Although congenital CMV infection is rare overall, it accounts for 21% of children with …
Long-term results of oral valganciclovir for treatment of anterior segment inflammation secondary to cytomegalovirus infection
… In our current study, we evaluated the use of oral valganciclovir for treating anterior segment
inflammation caused by CMV infection, and all patients had a minimum follow-up period of …
inflammation caused by CMV infection, and all patients had a minimum follow-up period of …
Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir
J Amir, DG Wolf, I Levy - European journal of pediatrics, 2010 - Springer
… The main side effect of treatment was transient neutropenia. In conclusion, prolonged …
congenital CMV infection with intravenous ganciclovir followed by oral valganciclovir is safe, and it …
congenital CMV infection with intravenous ganciclovir followed by oral valganciclovir is safe, and it …
[HTML][HTML] Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients
… of localized CMV infection (CMV inclusion cells or in situ detection of … with CMV disease,
oral valganciclovir has comparable safety and is not inferior to standard iv ganciclovir treatment …
oral valganciclovir has comparable safety and is not inferior to standard iv ganciclovir treatment …
相关搜索
- congenital cytomegalovirus infection
- cytomegalovirus infection oral valganciclovir
- cytomegalovirus infection ganciclovir therapy
- cytomegalovirus infection transplant recipients
- antiviral treatment of cytomegalovirus infection
- immunocompromised patients management of cmv infection
- symptomatic congenital cytomegalovirus infection ganciclovir treatment
- cytomegalovirus retinitis valganciclovir in the treatment
- organ transplantation management of cytomegalovirus infection
- treatment of cytomegalovirus infection and disease
- cytomegalovirus infection intravenous ganciclovir
- cytomegalovirus infection antiviral therapy
- treatment of cytomegalovirus infection immunocompromised hosts
- treatment of cytomegalovirus infection prospective assessment
- cytomegalovirus infection management of newborns
- cytomegalovirus infection treatment of children